Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,954,372 | 4,000,360 | 3,673,890 | 1,442,291 | 2,319,702 |
| Marketable Securities | N/A | 265,016 | 110,775 | N/A | 28,181 |
| Receivables | 4,930,589 | 4,457,858 | 4,452,564 | 5,253,542 | 4,369,885 |
| Inventories | 2,839,715 | 2,842,485 | 2,630,389 | 2,549,450 | 2,644,386 |
| Other current assets | 357,264 | 1 | 2 | 88,323 | 0 |
| TOTAL | $10,081,940 | $11,565,720 | $10,867,620 | $9,333,606 | $9,362,154 |
| Non-Current Assets | |||||
| PPE Net | 7,701,211 | 7,838,225 | 7,459,146 | 7,512,465 | 7,577,595 |
| Investments And Advances | 252,474 | 256,381 | 273,245 | 254,783 | 271,019 |
| Intangibles | 3,164,652 | 1,478,155 | 854,445 | 862,273 | 874,667 |
| Other Non-Current Assets | 1,001,773 | 833,199 | 650,618 | 684,886 | 743,803 |
| TOTAL | $12,120,110 | $10,405,960 | $9,237,453 | $9,314,406 | $9,467,084 |
| Total Assets | $22,202,050 | $21,971,680 | $20,105,070 | $18,648,010 | $18,829,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,142,719 | 230,476 | 207,962 | 183,739 | 220,953 |
| Accounts payable and accrued liabilities | 875,844 | 961,311 | 1,323,540 | 789,309 | 953,064 |
| Other current liabilities | 8,147,789 | 9,159,065 | 7,831,350 | 7,881,125 | 7,036,156 |
| TOTAL | $10,765,820 | $11,138,840 | $9,937,847 | $9,332,720 | $8,841,552 |
| Non-Current Liabilities | |||||
| Long Term Debt | 443,820 | 413,852 | 403,960 | 423,308 | 451,049 |
| aiOther Non-Current Liabilities | 907,710 | 910,443 | 858,137 | 849,127 | 891,455 |
| TOTAL | $1,734,837 | $1,479,882 | $1,297,249 | $1,280,559 | $1,354,496 |
| Total Liabilities | $12,500,660 | $12,618,720 | $11,235,100 | $10,613,280 | $10,196,050 |
| Shareholders' Equity | |||||
| Common Shares | 72,004 | 73,790 | 69,419 | 70,896 | 71,952 |
| Retained earnings | 9,770,177 | 9,396,450 | 8,864,067 | 8,101,936 | 8,666,769 |
| Other shareholders' equity | -139,791 | -116,279 | -63,510 | -136,100 | -104,531 |
| TOTAL | $9,701,390 | $9,352,961 | $8,869,976 | $8,034,732 | $8,633,190 |
| Total Liabilities And Equity | $22,202,050 | $21,971,681 | $20,105,076 | $18,648,012 | $18,829,240 |